The goal of this study was to use RNA-Seq to comprehensively identify alterations in miRNAs in ERα-positive, luminal A MCF-7 and MDA-MB-231 TNBC breast cancer cell lines treated with AnAc 24:1n5. This evidence concerns the gene ESR1 and breast carcinoma.